logo

For the Inventor, By the Inventor

Wallingford, CT, United States of America

Kerry Jeanne Combs

This inventor holds 4 USPTO granted patents. Top assignee: Bayer Corporation. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kerry Jeanne Combs. Retrieved from https://idiyas.com/inventor/kerry-jeanne-combs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 9.6

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal4 out of 1,013 
 
Bayer Corporation
 patents

Years Active: 1998-2000

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6166082 - Substituted 5-biarylpentanoic acids and derivatives as matrix (2000-12-26),
2. 5874473 - Substituted cycloalkanecarboxylic acid derivatives as matrix (1999-02-23),
3. 5859047 - Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease (1999-01-12),
4. 5789434 - Derivatives of substituted 4-biarylbutyric acid as matrix (1998-08-04),

Title: Kerry Jeanne Combs: Innovator in Pharmaceutical Chemistry

Introduction

Kerry Jeanne Combs is a distinguished inventor based in Wallingford, CT (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of matrix metalloprotease inhibitors. With a total of 4 patents to her name, Combs has established herself as a key figure in her area of expertise.

Latest Patents

Among her latest patents are innovative compounds such as substituted 5-biarylpentanoic acids and derivatives. These compounds serve as matrix inhibitors for matrix metalloproteases and are included in pharmaceutical compositions aimed at treating various physiological conditions. The generalized formula for these compounds highlights their complex structure, which includes substituent groups and various side chains of naturally occurring amino acids.

Career Highlights

Kerry Jeanne Combs is currently associated with Bayer Corporation, where she continues to advance her research and development efforts. Her work has been pivotal in creating new therapeutic options for patients, showcasing her commitment to improving health outcomes through innovative science.

Collaborations

Throughout her career, Combs has collaborated with notable colleagues such as Harold C Kluender and Brian R Dixon. These partnerships have further enriched her research and contributed to the success of her projects.

Conclusion

Kerry Jeanne Combs exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…